Skip to main content

Month: April 2022

Optimi Health Opens Canada’s Largest GMP-Grade Licensed Psilocybin Cultivation Facility

Company will host in-person and virtual tours for media, investors, and residents on May 27, 2022. VANCOUVER, British Columbia, April 28, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it will be inaugurating its recently completed psilocybin cultivation facility with a grand opening event and reception for members of the media, investors and other stakeholders relevant to the Company’s developing position as a leading supplier in the field of psychedelic and functional mushrooms on Friday, May 27th, 2022. The Optimi Health executive team and advisory board will be welcoming guests and dignitaries from the psychedelic business space, the medical and public health fields, local and national politics, and the Indigenous community to celebrate...

Continue reading

Federal Home Loan Bank of Atlanta Declares a 3.74% Dividend for First Quarter 2022

ATLANTA, April 28, 2022 (GLOBE NEWSWIRE) — The board of directors of the Federal Home Loan Bank of Atlanta (FHLBank Atlanta) today approved a first quarter 2022 cash dividend at an annualized rate of 3.74 percent. “In the face of continuing economic uncertainty, FHLBank Atlanta remains focused on maintaining a financially stable cooperative for the benefit of our members,” said FHLBank Atlanta Chair of the Board, Rick Whaley. “The board of directors is happy to return value to our members through this first quarter dividend.” The dividend rate is 3.65 percentage points over the daily average Secured Overnight Financing Rate, also known as SOFR, for the first quarter of 2022. The dividend payout will be calculated based on shareholders’ capital stock held during that period and will be credited to shareholders’ daily investment...

Continue reading

Rich Geruson, NexOptic Chairman, Introduces Next Generation AI Data Compression for Video Imaging

VANCOUVER, British Columbia, April 28, 2022 (GLOBE NEWSWIRE) — NexOptic Technology Corp. (“NexOptic” or the “Company”) (TSX VENTURE: NXO) (OTCQB: NXOPF) (FSE: E3O1), an innovator in cutting-edge patented and patent-pending Artificial Intelligence (AI) introduced its latest AI offering today, an advanced cloud-based data compression method for video called, NexCompress™. Operating in the cloud, NexCompress™ is uniquely different to other NexOptic offerings to date but remains part of the ALIIS™ family. It is a patent-pending method for enhancing data compression of video content, offering industry significant savings in storage, bandwidth and energy consumption for video streaming applications. The Company is executing the first stages of its commercialization strategy for NexCompress, and will offer the technology to customers...

Continue reading

Innovative MedTech Acquires RX Vitality in a Share Exchange

Innovative MedTech Announces Acquisition BLUE ISLAND, Ill., April 28, 2022 (GLOBE NEWSWIRE) — Innovative MedTech, Inc. (the “Company”) (OTC: IMTH), a provider of health and wellness services, today announced that it has signed a share exchange agreement to acquire RX Vitality, Inc. (“RX Vitality”), a media and finance advisory company, in a stock transaction. “The Company remains committed to its strategy of growing its health and wellness services, as well as its healthcare digital wallet under development. We believe that this acquisition is a crucial step in our anticipated expansion, prior to going live with our digital wallet and mobile application, as the management of RX Vitality has a combined 100+ years experience in media, finance and technology,” said Michael Friedman, President and CEO of the Company. He...

Continue reading

Uniserve 3rd Quarter Results for the period ended February 28, 2022

VANCOUVER, British Columbia, April 28, 2022 (GLOBE NEWSWIRE) — Uniserve Communications Corporation (the “Company” or “Uniserve”) (TSXV: USS) a provider of IT solutions and services to business and residential customers in Canada wishes to announce third quarter and year to date fiscal 2022 financial results. Q3 and Q3 year to date fiscal 2022 revenue increased by 17% and 8% respectively as compared to the same periods in the prior fiscal year. Q3 fiscal 2022 Net Income was $76K and Q3 year to date fiscal 2022 Net Income was $342K, as compared to Net Income of $24K and Net loss of $294K respectively for the prior year fiscal periods. The Company will continue to focus on its operating results in fiscal 2022 by continuing to implement operational efficiencies, grow recurring revenues and enhance value added for its customers.Uniserve...

Continue reading

Proactive news headlines including Deepspatial, HighGold Mining, Ridgeline Minerals, PyroGenesis, CULT Food Science and GR Silver

New York, April 28, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:Mountain Valley MD updates on its technologies and pre-clinical progress across broad husbandry animal and human applications click here CleanSpark partners with Sustainable Bitcoin Standard to boost clean bitcoin mining click here Deepspatial joins the NielsenIQ Partner Network with NielsenIQ to empower businesses with AI-driven insights click here HighGold Mining is ‘too cheap to not buy’ says Stifel GMP as broker repeats ‘Buy’ rating click here Equity Metals confirms extension of promising NG-3 vein at the Silver Queen project in British Columbia click here AFC Energy’s hydrogen fuel cell to be showcased at flying...

Continue reading

Baltic Horizon Fund declares quarterly cash distribution of approx. EUR 1.56 million to investors

Northern Horizon Capital AS as the management company of Baltic Horizon Fund (the Fund) has approved a cash distribution of approx. 1.17% of the Fund’s Q1 2022 weighted average net asset value to its unitholders. This equals approx. EUR 1.56 million in total and EUR 0.013 per unit. The pay-out represents an increased rolling distribution yield of 6.3% for the past 12 months based on the closing unit price on the last day of Q1 2022 on the Nasdaq Tallinn stock exchange. In Q1 2022, the Fund generated an unaudited Generated Net Cash Flow (GNCF) from operations of approx. EUR 1.9 million. The Fund aims to have the distribution rate at 80% of quarterly GNCF and reinvest the remaining 20% into ongoing projects to boost future cash flows and property values. In total, the Fund has paid out EUR 7.18 million from the operating results of the...

Continue reading

National Seating & Mobility Awarded Home Care Accreditation from The Joint Commission

National Seating & Mobility announced that the company has again earned The Joint Commission’s Gold Seal of Approval® for Home Care Accreditation by demonstrating continuous compliance with its performance standards. NASHVILLE, Tenn., April 28, 2022 (GLOBE NEWSWIRE) — National Seating & Mobility (NSM), North America’s largest provider of comprehensive mobility solutions, announced that the company has again earned The Joint Commission’s Gold Seal of Approval® for Home Care Accreditation by demonstrating continuous compliance with its performance standards. The Gold Seal is a symbol of quality that reflects a health care organization’s commitment to providing safe and quality patient care. “NSM is proud to be awarded Home Care re-accreditation from The Joint Commission,” said Bill Mixon, NSM CEO. “This honor reflects...

Continue reading

Quantum Genomics Publishes its Results for Fiscal Year 2021 and Provides a Corporate Update

PARIS, April 28, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal products that act directly on the brain in order to address difficult-to-treat/resistant hypertension and heart failure, today reported its full year 2021 results. The annual financial statements were approved by the Board of Directors on 27 April 2022. Statutory auditor’s report is available on the Company’s website: www.quantum-genomics.com. The “Document d’Enregistrement Universel” including the financial report for fiscal year 2021 will be available on the company’s website in the coming days. Jean-Philippe Milon, CEO of Quantum Genomics, said: “In an environment still impacted by the pandemic crisis, we continued our research...

Continue reading

LECTRA: Q1 2022: strong growth in orders, revenues and earnings

Q1 2022: strong growth in orders, revenues and earningsRevenues: 122.0 million euros (+83%) EBITDA before non-recurring items: 21.6 million euros (+90%) Net income: 9.3 million euros (+55%) Free cash flow before non-recurring items: 7.1 million eurosin millions of euros January 1 – March 31  2022 2021Revenues 122.0 66.7Change (%) +83%  EBITDA before non-recurring items(1) 21.6 11.4Change (%) +90%  EBITDA margin before non-recurring items (in % of revenues) 17.7% 17.0%Net income 9.3 6.0Change (%) +55%  Free cash flow before non-recurring items(1) 7.1 9.8         (1)  The definition of the performance indicators is illustrated in the Financial Report at March 31, 2022 Paris, April 28, 2022. Today, Lectra’s Board of Directors, chaired by Daniel Harari, reviewed the unaudited consolidated financial statements...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.